Medable Partners with Seqster to Integrate RWD into Decentralized Trials


Medable Inc. has announced a new partnership with Seqster to integrate real-time, real-world data streams into decentralized clinical trials in efforts to improve trial recruitment and participation.

“Patients want clinical trials to fit into their real-world experience, not the other way around,” said Dr. Michelle Longmire, CEO and co-founder of Medable. “Working with Seqster, we can integrate data sources and data streams to provide clinicians with a more holistic view of patient health.”

Medable and Seqster are also partnering with Datavant to integrate and link de-identified data across the entire patient journey, including electronic health records, claims, and diagnostics, as well as emerging sources such as genomics, wearable devices, socioeconomic and behavioral data and more.

For more information, click here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.